X-41665359-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001367721.1(CASK):c.626T>C(p.Leu209Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001367721.1 missense
Scores
Clinical Significance
Conservation
Publications
- FG syndrome 4Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- syndromic X-linked intellectual disability Najm typeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- X-linked syndromic intellectual disabilityInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001367721.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CASK | NM_001367721.1 | MANE Select | c.626T>C | p.Leu209Pro | missense | Exon 7 of 27 | NP_001354650.1 | ||
| CASK | NM_003688.4 | c.626T>C | p.Leu209Pro | missense | Exon 7 of 27 | NP_003679.2 | |||
| CASK | NM_001410745.1 | c.626T>C | p.Leu209Pro | missense | Exon 7 of 26 | NP_001397674.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CASK | ENST00000378163.7 | TSL:5 MANE Select | c.626T>C | p.Leu209Pro | missense | Exon 7 of 27 | ENSP00000367405.1 | ||
| CASK | ENST00000421587.8 | TSL:1 | c.644T>C | p.Leu215Pro | missense | Exon 7 of 25 | ENSP00000400526.4 | ||
| CASK | ENST00000378166.9 | TSL:1 | c.626T>C | p.Leu209Pro | missense | Exon 7 of 25 | ENSP00000367408.5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Syndromic X-linked intellectual disability Najm type Pathogenic:2
de novo variant in individual with severe postnatal microcephaly, delayed psychomotor development, nystagmus, etc
not provided Pathogenic:1
The L209P variant in the CASK gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The L209P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The L209P variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret L209P as a likely pathogenic variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at